Keefe Bruyette analyst Christopher O’Connell lowered the firm’s price target on BCB Bancorp (BCBP) to $13.75 from $15 and keeps a Market Perform rating on the shares. Published first on TheFly ...

In a report released today, Christopher O’Connell from KBW maintained a Hold rating on BCB Bancorp (BCBP – Research Report), with a price target of $15.00. The company’s shares closed ...

The BCB is proud to be a part of Tahsin's journey. "We feel that this is also a way of expressing our deepest gratitude to GM Ziaur Rahman for his contribution to the game of chess and to our ...

For the first time in almost 20 years, Walmart has a new logo. The international retailer describes it as a “a comprehensive brand refresh,” but the online world hasn’t been quite so kind to ...

Walmart is giving its logo the first facelift in nearly two decades, rolling out a new identity that is a subtle nod to its past. The 61-year-old company unveiled Monday a refresh of its brand ...

Shakib Al Hasan is awaiting the result of a second test of his bowling action from Chennai in India after failing his previous assessment from UK's Loughborough University that had left him ...

Walmart is refreshing its logo for the first time in nearly two decades, highlighting its evolution while also serving as a nod to its past, the big-box retailer announced Monday. The word mark on ...

Here are some before and after pictures of the company's wordmark and logo. Need a break? Play the USA TODAY Daily Crossword Puzzle. Here's a look at how the new wordmark and logo will appear on ...

Walmart’s latest brand and logo update has left some social media users baffled. On Jan. 13, the company announced in a press release on its website that it was launching a “comprehensive ...

Walmart steel cage match (although we would totally watch). Instead, Walmart gave its logo a makeover fit for modern times—at least that was the idea. But people, well, they have feelings.

The Company has aligned on clinical plan based on a positive FDA meeting, leveraging clinical data from a first-in-human Phase 1 trial published today in Nature Medicine BCB-276 uses repetitive ...